Stock Track | Liquidia Technologies Soars 5% in Pre-Market on Strong Q4 Results, Revenue Beat and Return to Profitability

Stock Track

03/05

Liquidia Technologies Inc's stock surged 5.00% in pre-market trading following the release of its fourth quarter and full year 2025 financial results.

The company reported a significant swing to profitability in the fourth quarter, with net income of $14.6 million compared to a loss of $38.5 million in the same period last year. Revenue for the quarter reached $92.02 million, surpassing analyst consensus estimates of $87.49 million. This marks the company's second consecutive quarter of profitability since launching its YUTREPIA product.

Liquidia's CEO, Dr. Roger Jeffs, highlighted the strong commercial performance of YUTREPIA, which achieved net product sales of $148.3 million for the full year 2025, with $90.1 million coming in the fourth quarter alone. The company reported more than 3,600 unique prescriptions and over 2,900 patients treated since the product's launch in June 2025, indicating robust market adoption and growth trajectory.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1189821899"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1189821899\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1189821899?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-05 20:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189821899","market":"nz","top_or_hot":-1,"title":"Stock Track | Liquidia Technologies Soars 5% in Pre-Market on Strong Q4 Results, Revenue Beat and Return to Profitability","media":"Stock Track","content":"<p>Liquidia Technologies Inc's stock surged 5.00% in pre-market trading following the release of its fourth quarter and full year 2025 financial results.</p><p>The company reported a significant swing to profitability in the fourth quarter, with net income of $14.6 million compared to a loss of $38.5 million in the same period last year. Revenue for the quarter reached $92.02 million, surpassing analyst consensus estimates of $87.49 million. This marks the company's second consecutive quarter of profitability since launching its YUTREPIA product.</p><p>Liquidia's CEO, Dr. Roger Jeffs, highlighted the strong commercial performance of YUTREPIA, which achieved net product sales of $148.3 million for the full year 2025, with $90.1 million coming in the fourth quarter alone. The company reported more than 3,600 unique prescriptions and over 2,900 patients treated since the product's launch in June 2025, indicating robust market adoption and growth trajectory.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Liquidia Technologies Soars 5% in Pre-Market on Strong Q4 Results, Revenue Beat and Return to Profitability</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Liquidia Technologies Soars 5% in Pre-Market on Strong Q4 Results, Revenue Beat and Return to Profitability\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-05 20:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Liquidia Technologies Inc's stock surged 5.00% in pre-market trading following the release of its fourth quarter and full year 2025 financial results.</p><p>The company reported a significant swing to profitability in the fourth quarter, with net income of $14.6 million compared to a loss of $38.5 million in the same period last year. Revenue for the quarter reached $92.02 million, surpassing analyst consensus estimates of $87.49 million. This marks the company's second consecutive quarter of profitability since launching its YUTREPIA product.</p><p>Liquidia's CEO, Dr. Roger Jeffs, highlighted the strong commercial performance of YUTREPIA, which achieved net product sales of $148.3 million for the full year 2025, with $90.1 million coming in the fourth quarter alone. The company reported more than 3,600 unique prescriptions and over 2,900 patients treated since the product's launch in June 2025, indicating robust market adoption and growth trajectory.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LQDA","symbol_name":"Liquidia Technologies Inc","start_time":0,"source_url":"","article_id":"1189821899","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189821899","pubTimestamp":1772712162,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Liquidia Technologies Inc's stock surged 5.00% in pre-market trading following the release of its fourth quarter and full year 2025 financial results.The company reported a significant swing to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LQDA":"Liquidia Technologies Inc"},"translate_title":"个股追踪|Liquidia Technologies盘前大涨5%，Q4业绩强劲，营收超预期并恢复盈利","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LQDA":1},"content_text":"Liquidia Technologies Inc's stock surged 5.00% in pre-market trading following the release of its fourth quarter and full year 2025 financial results.The company reported a significant swing to profitability in the fourth quarter, with net income of $14.6 million compared to a loss of $38.5 million in the same period last year. Revenue for the quarter reached $92.02 million, surpassing analyst consensus estimates of $87.49 million. This marks the company's second consecutive quarter of profitability since launching its YUTREPIA product.Liquidia's CEO, Dr. Roger Jeffs, highlighted the strong commercial performance of YUTREPIA, which achieved net product sales of $148.3 million for the full year 2025, with $90.1 million coming in the fourth quarter alone. The company reported more than 3,600 unique prescriptions and over 2,900 patients treated since the product's launch in June 2025, indicating robust market adoption and growth trajectory.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}